IL98024A - Proteins of CD-44 surfaces, DNA sequences encoded by them and polypeptides encoded by said DNA sequences - Google Patents

Proteins of CD-44 surfaces, DNA sequences encoded by them and polypeptides encoded by said DNA sequences

Info

Publication number
IL98024A
IL98024A IL9802491A IL9802491A IL98024A IL 98024 A IL98024 A IL 98024A IL 9802491 A IL9802491 A IL 9802491A IL 9802491 A IL9802491 A IL 9802491A IL 98024 A IL98024 A IL 98024A
Authority
IL
Israel
Prior art keywords
aca
gaa
cat
acc
cag
Prior art date
Application number
IL9802491A
Other languages
English (en)
Hebrew (he)
Other versions
IL98024A0 (en
Original Assignee
Karlsruhe Forschzent
Krebsforschungszentrum
Univ Karlsruhe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karlsruhe Forschzent, Krebsforschungszentrum, Univ Karlsruhe filed Critical Karlsruhe Forschzent
Priority to IL13498291A priority Critical patent/IL134982A/en
Publication of IL98024A0 publication Critical patent/IL98024A0/xx
Priority to IL13498200A priority patent/IL134982A0/xx
Publication of IL98024A publication Critical patent/IL98024A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2884—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL9802491A 1990-05-07 1991-05-02 Proteins of CD-44 surfaces, DNA sequences encoded by them and polypeptides encoded by said DNA sequences IL98024A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL13498291A IL134982A (en) 1990-05-07 1991-05-02 Antibodies that react with variant polypeptides of CD-44 surface proteins of cancer metastatic cells and their prepared diagnostic and pharmaceutical preparations
IL13498200A IL134982A0 (en) 1990-05-07 2000-03-09 Antibodies which react with polypeptides of cd-44 surface proteins and diagnostic and pharmaceutical compositions prepared therewith

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4014510A DE4014510A1 (de) 1990-05-07 1990-05-07 Variante cd44-oberflaechenproteine, diese kodierende c-dna-sequenzen, antikoerper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie

Publications (2)

Publication Number Publication Date
IL98024A0 IL98024A0 (en) 1992-06-21
IL98024A true IL98024A (en) 2001-06-14

Family

ID=6405813

Family Applications (3)

Application Number Title Priority Date Filing Date
IL13498291A IL134982A (en) 1990-05-07 1991-05-02 Antibodies that react with variant polypeptides of CD-44 surface proteins of cancer metastatic cells and their prepared diagnostic and pharmaceutical preparations
IL9802491A IL98024A (en) 1990-05-07 1991-05-02 Proteins of CD-44 surfaces, DNA sequences encoded by them and polypeptides encoded by said DNA sequences
IL13498200A IL134982A0 (en) 1990-05-07 2000-03-09 Antibodies which react with polypeptides of cd-44 surface proteins and diagnostic and pharmaceutical compositions prepared therewith

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL13498291A IL134982A (en) 1990-05-07 1991-05-02 Antibodies that react with variant polypeptides of CD-44 surface proteins of cancer metastatic cells and their prepared diagnostic and pharmaceutical preparations

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL13498200A IL134982A0 (en) 1990-05-07 2000-03-09 Antibodies which react with polypeptides of cd-44 surface proteins and diagnostic and pharmaceutical compositions prepared therewith

Country Status (21)

Country Link
US (3) US5506119A (sh)
EP (1) EP0531300B1 (sh)
JP (1) JP3133062B2 (sh)
KR (1) KR0184691B1 (sh)
AT (1) ATE106943T1 (sh)
AU (1) AU646858B2 (sh)
BR (1) BR1100650A (sh)
CA (1) CA2082382C (sh)
DE (2) DE4014510A1 (sh)
DK (1) DK0531300T3 (sh)
FI (1) FI106128B (sh)
HU (1) HU218905B (sh)
IE (1) IE62096B1 (sh)
IL (3) IL134982A (sh)
NO (3) NO309770B1 (sh)
NZ (1) NZ238056A (sh)
PT (1) PT97574B (sh)
TW (1) TW212202B (sh)
WO (1) WO1991017248A1 (sh)
YU (1) YU49126B (sh)
ZA (1) ZA913389B (sh)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002873A (en) * 1989-03-17 1991-03-26 Fred Hutchinson Cancer Research Center DNA sequence encoding a lymphocyte adhesion receptor for high endothelium
US5443750A (en) * 1991-01-16 1995-08-22 The Procter & Gamble Company Detergent compositions with high activity cellulase and softening clays
DE4134982A1 (de) * 1991-10-23 1993-04-29 Kernforschungsz Karlsruhe Verwendung von antikoerper enthaltenden praeparationen zur immunsuppression
DE69302276T2 (de) * 1992-07-21 1996-09-19 Isis Innovation Diagnostische Methode
JPH08511419A (ja) 1993-06-18 1996-12-03 ヤルカネン、シルパ 組成物およびＣＤ４４ｖ６に対するモノクローナル抗体を用いる診断方法
DE4320623C2 (de) * 1993-06-22 1997-11-20 Boehringer Ingelheim Int Verfahren zur Diagnose und Analyse von Adenokarzinomen
EP0767378A1 (de) * 1993-06-22 1997-04-09 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Diagnose und Analyse von Magenkarzinomen
DE4320624A1 (de) * 1993-06-22 1995-02-09 Boehringer Ingelheim Int Verfahren zur Diagnose und Analyse von Mammakarzinomen
DE4326573A1 (de) * 1993-08-07 1995-02-23 Boehringer Ingelheim Int Durch Exon v5 des CD44-Gens kodierte Polypeptide als Targets für Immuntherapie und Immunszintigraphie von Tumoren
DE4431297A1 (de) * 1994-09-02 1996-03-07 Boehringer Ingelheim Int Monoklonaler Antikörper gegen CD44v6
DE19540515C1 (de) * 1995-10-31 1997-02-06 Boehringer Ingelheim Int Tumortherapie durch adoptiven Transfer CD44v-spezifischer zytotoxischer T-Lymphozyten
DE19653607A1 (de) 1996-12-20 1998-06-25 Boehringer Ingelheim Int Verfahren zur Diagnose und Therapie von Hodgkin-Lymphomen
DE19708713C2 (de) * 1997-03-04 2002-11-28 Boehringer Ingelheim Int Verwendung von anti-CD44 Antikörpern enthaltenden Präparationen zur Behandlung bestimmter Tumore und zur Unterdrückung von Immunreaktionen
US20080124327A1 (en) * 1999-10-08 2008-05-29 Arius Research, Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US8048416B2 (en) 1999-10-08 2011-11-01 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US20050100542A1 (en) * 1999-10-08 2005-05-12 Young David S. Cytotoxicity mediation of cells evidencing surface expression of CD44
US7947496B2 (en) * 1999-10-08 2011-05-24 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US8071072B2 (en) 1999-10-08 2011-12-06 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US7189397B2 (en) * 1999-10-08 2007-03-13 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US20090004103A1 (en) * 1999-10-08 2009-01-01 Young David S F Cytotoxicity mediation of cells evidencing surface expression of CD44
DE10026833A1 (de) * 2000-05-30 2001-12-13 Karlsruhe Forschzent Verfahren zur Identifizierung von Verbindungen zur Modulierung der Aktivität eines Tumorsuppressorgens
AU2003272511A1 (en) * 2002-09-13 2004-04-30 Dyax Corporation Cd44-binding ligands
PL2886126T3 (pl) 2013-12-23 2017-11-30 Exchange Imaging Technologies Gmbh Nanocząstka sprzężona z peptydami wiążącymi CD44
CN109608537B (zh) * 2018-12-12 2020-09-15 深圳市龙华区人民医院 基于前列腺癌干细胞标志物cd44的抗原表位多肽cd44-p2及其应用
CN109608536B (zh) * 2018-12-12 2020-09-15 深圳市龙华区人民医院 基于前列腺癌干细胞标志物cd44的抗原表位多肽cd44-p3及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753894A (en) * 1984-02-08 1988-06-28 Cetus Corporation Monoclonal anti-human breast cancer antibodies
US5108904A (en) * 1990-03-26 1992-04-28 Alan Landay CD44 as a marker for HIV infection

Also Published As

Publication number Publication date
NO924234L (no) 1993-01-04
FI925043A0 (fi) 1992-11-06
AU646858B2 (en) 1994-03-10
NO20001668D0 (no) 2000-03-31
IL98024A0 (en) 1992-06-21
YU49126B (sh) 2004-03-12
NZ238056A (en) 1993-01-27
NO924234D0 (no) 1992-11-04
NO980293D0 (no) 1998-01-23
DE4014510A1 (de) 1991-11-14
EP0531300A1 (de) 1993-03-17
TW212202B (sh) 1993-09-01
US5760178A (en) 1998-06-02
NO310661B1 (no) 2001-08-06
IE62096B1 (en) 1995-01-11
WO1991017248A1 (de) 1991-11-14
HU9203449D0 (en) 1993-01-28
PT97574A (pt) 1992-01-31
FI106128B (fi) 2000-11-30
US5506119A (en) 1996-04-09
CA2082382C (en) 2008-09-30
JP3133062B2 (ja) 2001-02-05
PT97574B (pt) 1998-08-31
IE911526A1 (en) 1991-11-20
FI925043A (fi) 1992-11-06
NO317154B1 (no) 2004-08-30
KR0184691B1 (ko) 1999-04-01
IL134982A (en) 2004-05-12
NO309770B1 (no) 2001-03-26
DK0531300T3 (da) 1994-10-10
ZA913389B (en) 1992-03-25
JPH05508309A (ja) 1993-11-25
HUT63652A (en) 1993-09-28
CA2082382A1 (en) 1991-11-08
DE59101889D1 (de) 1994-07-14
IL134982A0 (en) 2001-05-20
BR1100650A (pt) 2000-08-08
YU79491A (sh) 1994-06-10
EP0531300B1 (de) 1994-06-08
NO20001668L (no) 1993-05-06
ATE106943T1 (de) 1994-06-15
US5885575A (en) 1999-03-23
HU218905B (hu) 2000-12-28
NO980293L (no) 1993-01-04
AU7565991A (en) 1991-11-27

Similar Documents

Publication Publication Date Title
IL98024A (en) Proteins of CD-44 surfaces, DNA sequences encoded by them and polypeptides encoded by said DNA sequences
JP4327350B2 (ja) エピトープへの結合能力を保持する結合部位ドメインの同定のための新規方法
US7259247B1 (en) Anti-human T-cell costimulating polypeptide monoclonal antibodies
US7132099B2 (en) Methods of modulating T lymphocyte costimulation with an antibody to an 8F4 polypeptide
US8426565B2 (en) Dendritic cell marker and uses thereof
CA2177988A1 (en) Expression vector for preparing an anti-body-variable-region library
JP2002507398A (ja) ヒト・モノクローナル抗体およびそのための使用の開発
US5536641A (en) Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1 and uses thereof for detection of, and isolation of, vascular endothelial cells
WO1995015340A1 (en) Monoclonal antibodies to antigens expressed by human dendritic cells
WO1991010722A2 (en) Chimeric immunoglobulin for cd4 receptors
KR100518958B1 (ko) 신규한 유전자 클로닝 방법
FI106129B (fi) Menetelmät valmistaa muuntuneita CD44-pintaproteiineja ja näitä proteiineja vastaan vaikuttavia vasta-aineita
JP3447322B2 (ja) マウス細胞表面抗原に対するハムスターモノクローナル抗体
Pata et al. Three different immunogen preparation strategies for production of CD4 monoclonal antibodies
Yamashita et al. Tissue-specific and growth-regulated expression of CD44 variable exon determinants in the mouse
WO2004009832A1 (en) High throughput production of antibodies to genomic-derived proteins
JPH07115988A (ja) 可溶性膜タンパクの製造方法及び可溶性膜タンパク

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees